![]() |
|
|
Molecular Pharmacology, Vol 20, 415-422, Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics
,
) and Herpes Simplex Virus (Types 1, 2) DNA
Polymerases
1 Department of Pharmacology, School of Medicine, and Drug Development Program, Cancer Research Center, University of
North Carolina, Chapel Hill, North Carolina 27514
Many pyrimidine nucleoside analogues exhibit potent anti-herpesvirus activity. Analogues
of current interest in several laboratories include 5-propyl-2'-deoxyuridine, E-5-propenyl-2'-deoxyuridine, E-5-(2-bromovinyl)-2'-deoxyuridine, E-5-(2-bromovinyl)-1-
-D-arabinofuranosyluracil, 1-(2-deoxy-2-fluoro-
-D-arabinofuranosyl)-thymine (2'-fluoro-araT), 1-(2-deoxy-2-fluoro-
-D-arabinofuranosyl)-5-methylcytosine, and 1-(2-deoxy-2-fluoro-
-D-arabinofuranosyl)-5-iodocytosine. To aid in establishing the mechanisms of action and basis
for selectivities of these seven analogues, the 5'-triphosphates were prepared for testing
with DNA polymerases; a general method for the direct chemical synthesis of nucleoside
triphosphate from nucleoside is described. The effects of the analogue triphosphates were
evaluated on the following four isolated DNA polymerases: virus-induced DNA polymerases from herpes simplex virus Type 1 (HSV-1) and Type 2 (HSV-2) infections, and
human DNA polymerases
and
, using conditions optimal for each. Compounds were
evaluated for (a) competitive inhibition with regard to both dTTP and dCTP as independently competing substrates; (b) ability to support DNA synthesis in the absence of
normally competing substrate; and (c) the effect of analogue incubation on primer
template capability of resultant DNA. Competitive inhibition results indicate that all
seven analogue triphosphates (a) are good inhibitors of normal substrate utilization by
DNA polymerase regardless of enzyme source, (b) have much higher apparent affinities
(20- to 600-fold lower Ki) for HSV polymerases than for human polymerases, and (c) are
equally inhibitory to both HSV-1 and HSV-2 DNA polymerases. For example, the
apparent inhibition constant (Ki) of 2'-fluoro-araTTP was 0.048 µM for HSV-1 (Km of
dTTP = 0.14 µM), 0.060 µM for HSV-2 (Km of dTTP = 0.18 µM), 1.2 µM for human
polymerase-
(Km of dTTP = 5.4 µM), and 18 µM for human polymerase-
(Km of dTTP
= 8.6 µM); the relative abilities of competitive inhibition (in order of decreasing binding
affinity as reflected by increasing Ki) were E-5-(2-bromovinyl)-araUTP > 2'-fluoroarabinoside triphosphates > E-5-(2-bromovinyl)-dUTP > E-5-propenyl-dUTP > 5-propyl-dUTP for all polymerases except human
. The analogues varied considerably in
support of DNA synthesis in the absence of normally competing substrate, again with
little difference between polymerases; for example, regardless of enzyme source, 5-propyl-dUTP in the absence of dTTP resulted in 60-70% DNA synthesis relative to dTTP,
whereas E-5-(2-bromovinyl)-araUTP gave little or no DNA synthesis, suppressing polymerase activity below background levels. The relative ability to support DNA synthesis
was generally E-5-propenyl-dUTP
dTTP > E-5-(2-bromovinyl-dUTP) > 5-propyl-dUTP » 2'-fluoro-arabinonucleoside triphosphates » E-5-(2-bromovinyl)-araUTP. Incubation of analogue triphosphates and polymerase with activated DNA suggests that,
with E-5-(2-bromovinyl)-araUTP as the exception, the analogues have little effect on the
subsequent ability of product DNA to serve as primer template. E-5-Propenyl-dUTP
exhibited behavior markedly the most similar to dTTP throughout these studies. Some
general observations concerning structure-activity relationships are discussed.
Note:
ACKNOWLEDGMENTS
We thank Mr. David Derse of this laboratory for providing us with
the purified DNA polymerases and much needed advice, and our
colleagues Drs. Richard Walker, Eric De Clercq, Haruhiko Machida,
and Jack Fox for providing many of the test compounds as nucleosides.
This article has been cited by other articles:
![]() |
C.-H. Hsu, R. Hu, G. E. Dutschman, G. Yang, P. Krishnan, H. Tanaka, M. Baba, and Y.-C. Cheng Comparison of the Phosphorylation of 4'-Ethynyl 2',3'-Dihydro-3'-Deoxythymidine with That of Other Anti-Human Immunodeficiency Virus Thymidine Analogs Antimicrob. Agents Chemother., May 1, 2007; 51(5): 1687 - 1693. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Hu, L. Li, B. Degreve, G. E. Dutschman, W. Lam, and Y.-C. Cheng Behavior of Thymidylate Kinase toward Monophosphate Metabolites and Its Role in the Metabolism of 1-(2'-Deoxy-2'-Fluoro-{beta}-L-Arabinofuranosyl)-5-Methyluracil (Clevudine) and 2',3'-Didehydro-2',3'-Dideoxythymidine in Cells Antimicrob. Agents Chemother., May 1, 2005; 49(5): 2044 - 2049. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Hsu, J.-Y. Liou, G. E. Dutschman, and Y.-C. Cheng Phosphorylation of Cytidine, Deoxycytidine, and Their Analog Monophosphates by Human UMP/CMP Kinase Is Differentially Regulated by ATP and Magnesium Mol. Pharmacol., March 1, 2005; 67(3): 806 - 814. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Lam, Y. Li, J.-Y. Liou, G. E. Dutschman, and Y.-c. Cheng Reverse Transcriptase Activity of Hepatitis B Virus (HBV) DNA Polymerase within Core Capsid: Interaction with Deoxynucleoside Triphosphates and Anti-HBV L-Deoxynucleoside Analog Triphosphates Mol. Pharmacol., February 1, 2004; 65(2): 400 - 406. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-m. Chou and Y.-c. Cheng The Exonuclease Activity of Human Apurinic/Apyrimidinic Endonuclease (APE1). BIOCHEMICAL PROPERTIES AND INHIBITION BY THE NATURAL DINUCLEOTIDE Gp4G J. Biol. Chem., May 9, 2003; 278(20): 18289 - 18296. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Liou, P. Krishnan, C.-C. Hsieh, G. E. Dutschman, and Y.-c. Cheng Assessment of the Effect of Phosphorylated Metabolites of Anti-Human Immunodeficiency Virus and Anti-Hepatitis B Virus Pyrimidine Analogs on the Behavior of Human Deoxycytidylate Deaminase Mol. Pharmacol., January 1, 2003; 63(1): 105 - 110. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Krishnan, J.-Y. Liou, and Y.-C. Cheng Phosphorylation of Pyrimidine L-Deoxynucleoside Analog Diphosphates. KINETICS OF PHOSPHORYLATION AND DEPHOSPHORYLATION OF NUCLEOSIDE ANALOG DIPHOSPHATES AND TRIPHOSPHATES BY 3-PHOSPHOGLYCERATE KINASE J. Biol. Chem., August 23, 2002; 277(35): 31593 - 31600. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Krishnan, Q. Fu, W. Lam, J.-Y. Liou, G. Dutschman, and Y.-C. Cheng Phosphorylation of Pyrimidine Deoxynucleoside Analog Diphosphates. SELECTIVE PHOSPHORYLATION OF L-NUCLEOSIDE ANALOG DIPHOSPHATES BY 3-PHOSPHOGLYCERATE KINASE J. Biol. Chem., February 8, 2002; 277(7): 5453 - 5459. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Li, G. E. Dutschman, E. A. Gullen, E. Tsujii, S. P. Grill, Y. Choi, C. K. Chu, and Y.-c. Cheng Metabolism and Mode of Inhibition of Varicella-Zoster Virus by L-beta -5-Bromovinyl-(2-hydroxymethyl)-(1,3-dioxolanyl)uracil Is Dependent on Viral Thymidine Kinase Mol. Pharmacol., November 1, 2000; 58(5): 1109 - 1114. [Abstract] [Full Text] |
||||
![]() |
S. Lin, W. J. Henzel, S. Nayak, and D. Dennis Photoaffinity Labeling by 4-Thiodideoxyuridine Triphosphate of the HIV-1 Reverse Transcriptase Active Site during Synthesis. SEQUENCE OF THE UNIQUE LABELED HEXAPEPTIDE J. Biol. Chem., January 9, 1998; 273(2): 997 - 1002. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Prober, G. Trainor, R. Dam, F. Hobbs, C. Robertson, R. Zagursky, A. Cocuzza, M. Jensen, and K Baumeister A system for rapid DNA sequencing with fluorescent chain-terminating dideoxynucleotides Science, October 16, 1987; 238(4825): 336 - 341. [Abstract] [PDF] |
||||
![]() |
K.-M. Chou, M. Kukhanova, and Y.-C. Cheng A Novel Action of Human Apurinic/Apyrimidinic Endonuclease. EXCISION OF L-CONFIGURATION DEOXYRIBONUCLEOSIDE ANALOGS FROM THE 3' TERMINI OF DNA J. Biol. Chem., September 29, 2000; 275(40): 31009 - 31015. [Abstract] [Full Text] [PDF] |
||||